Dividend history
Supernus Pharmaceuticals, Inc.
SUPN.US
Recent payments
$8.1300USD
Ex: Nov 3, 2026
Pay: Nov 6
Supernus Pharmaceuticals went ex-dividend on November 3, 2026. Here’s what that means for shareholders.
Supernus Pharmaceuticals, Inc. (SUPN.US) declared a dividend of CA$8.13 USD per common share, with payment scheduled for November 6, 2026. Investors who bought shares on November 3 or later were not eligible for this payment.
Investor takeaway: The ex-dividend date has passed, so new buyers are not eligible for this payment. The supplied history lists one payment and no detected increases. That limited record doesn’t show whether the company will pay dividends regularly in the future.
Supernus Pharmaceuticals, Inc.
SUPN.US
SUPN.US
Supernus Pharmaceuticals, Inc.
WealthAwesomeMarket cap
$1.64B
52W high
$33.22
52W low
$21.48
1W change
-31.27%
Beta
0.52
Analyst Price Targets
Based on 4 analysts covering SUPN · as of Oct 16, 2026
Wall Street analysts forecast SUPN stock price to rise 114.9% over the next 12 months.
Consensus
Strong Buy4.50 / 5.00
Avg. Target
C$60.50
+114.9% Upside
Previously C$61.75 on Oct 5, 2026
Current Price
C$28.15
Last close
Analyst Breakdown (4 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SUPN's historical volatility
30-Day Vol
120.2%
Annualized
90-Day Vol
75.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$23.55
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$26.52 | C$17.52 – C$40.16 |
| 60 trading days | C$24.99 | C$13.90 – C$44.93 |
| 90 trading days | C$23.55 | C$11.48 – C$48.30 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Dividend amount: CA$8.13 USD per share
The listed dividend is CA$8.13 USD per common share. The ex-dividend date was November 3, 2026, and the payment date is November 6, 2026.
What “ex-dividend” means
The ex-dividend date is the first day a buyer is no longer eligible for a declared dividend. To qualify for this payment, investors needed to own shares before November 3. The record date was October 30, 2026.
Payment date and dividend history
The payment is scheduled for November 6, 2026. The supplied data lists one payment, covering about zero years, and no detected increases. That short history doesn’t establish a regular payment schedule or indicate whether future dividends will be paid. The listed trailing yield is 0.00%.
Following SUPN.US as a Canadian investor
Visit the Supernus Pharmaceuticals stock page for company and share information. The dividend is listed as CA$8.13 USD, but the supplied facts don’t provide an exchange rate or a separate Canadian-dollar conversion. Since the ex-dividend date has passed, investors buying now aren’t eligible for this payment.
Dividend calendar
| Ticker | SUPN.US |
| Amount | CA$8.13 |
| Ex-dividend | 2026-11-03 |
| Record | 2026-10-30 |
| Payment | 2026-11-06 |
| Declared | 2026-09-16 |
| Trailing yield | 0.00% |
| Stock page | SUPN.US dividend history |
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
